These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis. Luxton G; Langham R; Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120 [No Abstract] [Full Text] [Related]
3. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis. Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G; Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121 [No Abstract] [Full Text] [Related]
4. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies. Raman G; Srivastava A; Geetha D Transplantation; 2012 Sep; 94(5):e30-1. PubMed ID: 22955170 [No Abstract] [Full Text] [Related]
5. [Rapid recurrence of ANCA-MPO positive vasculitis after non-heart beating donor renal transplantation]. López Montes A; Márquez Vidas M; Alvarez Flores T; González López L; Sánchez Fructuoso A; Blanco J; Barrientos A Nefrologia; 2006; 26(2):278-82. PubMed ID: 16808269 [TBL] [Abstract][Full Text] [Related]
6. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Gera M; Griffin MD; Specks U; Leung N; Stegall MD; Fervenza FC Kidney Int; 2007 Jun; 71(12):1296-301. PubMed ID: 17410100 [TBL] [Abstract][Full Text] [Related]
7. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Moran S; Little MA Curr Opin Rheumatol; 2014 Jan; 26(1):37-41. PubMed ID: 24257368 [TBL] [Abstract][Full Text] [Related]